i2b2 tranSMART Foundation

What i2b2 tranSMART Foundation does

The i2b2 tranSMART Foundation is a non-profit open-source foundation that develops and stewards clinical and translational research informatics platforms used by academic medical centers, pharmaceutical companies, and healthcare systems. Formed in May 2017 through the merger of the i2b2 Foundation (established 2004) and the tranSMART Foundation (established 2013), it is headquartered in Needham, Massachusetts and operates with NIH/NCATS designation as a National Center for Biomedical Computing. Its core technology portfolio includes i2b2 (an informatics framework integrating clinical and research data), tranSMART (a translational research knowledge management platform), SHRINE (a federated query network enabling cross-institution cohort discovery), and the i2b2 Docker deployment package. The foundation reports 110+ member organizations and 200+ hospital installations worldwide.

The platform architecture is built on standard open-source components (Java, Postgres, web app stacks) and is designed for self-hosting inside institutional firewalls, which is a key adoption driver for hospital IT and research compliance teams handling protected health information. Beyond the core data-integration stack, the foundation has layered on analytics capabilities including the Computational Phenotype Pipeline (predictive phenotype classification deployed at multiple hospitals) and the Personalized Digital Medical Twin (developed in collaboration with Dell Technologies for individual-level explainable AI modeling). Governance and roadmap are set by the foundation board, with advisory input from recognized informatics leaders including Isaac Kohane and Griffin Weber.

The business model is non-commercial: the software is freely distributed under an open-source license, and the foundation's revenue comes from institutional membership dues, NIH and federal grant funding, and corporate sponsorships. The foundation does not sell licenses, charge for support, or generate per-seat revenue; members contribute code, governance participation, and dues in exchange for roadmap influence and access to the shared community. This structure inherently caps revenue growth relative to community/adoption growth and makes the foundation's financial trajectory a function of grant cycles and sponsor renewals rather than enterprise sales expansion.

Name

i2b2 tranSMART Foundation

Legal name

i2b2 tranSMART Foundation

Website

https://i2b2transmart.org

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

The i2b2 tranSMART Foundation is a non-profit open-source foundation that develops clinical and translational research informatics platforms (i2b2, tranSMART, SHRINE) for academic medical centers, pharmaceutical companies, and healthcare systems, sustaining operations via membership dues, NIH grants, and corporate sponsorships.

Ownership category

akta.pro rank

Product category

Clinical Research Informatics Software

NAICS

Computer Systems Design and Related Services (54151), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Clinical research informatics
• Translational research platforms
• Biomedical data integration
• Precision medicine software
• Open-source healthcare

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Sponsorship Programs: Non-profit foundation funded through Contributing Sponsors (academic institutions, healthcare organizations) and Corporate Sponsors that provide financial support for foundation operations and events.
2. Grant Funding: NIH-funded research initiatives including grants for COVID-19 research, National Centers for Biomedical Computing (NCBC), and other translational research programs.
3. Community Membership: Membership program with over 110 members including academic, corporate, non-profit, patient advocacy and government organizations paying annual dues.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Core offering

The i2b2 tranSMART Foundation develops and distributes open-source software platforms (i2b2, tranSMART, and SHRINE) for clinical and translational research. These platforms enable academic medical centers, pharmaceutical companies, and healthcare systems to integrate, standardize, analyze, and share heterogeneous biomedical, genomic, and clinical data to support precision medicine research, cohort identification, and clinical trial design.

Product overview

The i2b2 tranSMART Foundation develops a suite of open-source software platforms for clinical and translational research in precision medicine. The core offerings include i2b2 (clinical data integration and analysis platform), tranSMART (data management system), and SHRINE (federated query software). The i2b2 platform latest version 1.8.2 provides secure software framework, patient counting, ontology integration, and data export workflows. The Docker working group maintains containerized deployment options. The Foundation merged i2b2 and tranSMART in 2017 to create an integrated ecosystem supporting over 200 hospital installations worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• i2b2: Open-source clinical research data management platform for integrating and analyzing heterogeneous data from healthcare and research
• tranSMART
• SHRINE

Products and services

• i2b2 Platform Open-source clinical data integration and analysis platform for biomedical informatics that enables researchers to integrate, analyze, and visualize heterogeneous data from healthcare and research to advance precision medicine. Latest release 1.8.2 includes Secure Software Framework updates, ACT Ontology v4.2 Integration, and new Data Export Workflow.
• tranSMART Platform Open-source data management system for clinical and translational research that enables cross-study data analysis and pre-competitive data sharing across pharmaceutical, academic, and government organizations.
• SHRINE Open-source software enabling federated queries across multiple i2b2 instances, allowing researchers to query patient data across institutional boundaries while maintaining data governance.
• i2b2 Docker Containerized Docker image that streamlines new i2b2 installations, facilitates seamless upgrades, and ensures critical security updates for enhanced efficiency, scalability, and reliability.

Quantifiable outcome

• Six hospitals have adopted the Computational Phenotype Pipeline, enabling access to open-source database and advanced analytics not previously available
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Dell TechnologiescoreStrategic or Co-development Partner · 5 May 2021Collaboration on Personalized Digital Medical Twin initiative using explainable AI and de-identified patient data to create virtual patient models for treating long-haul COVID-19. Dell Technologies provides modern infrastructure enabling data mobilization from 200 hospitals and research centers, 50 academic medical centers, and pharmaceutical companies. Joint initiative enables millions of individualized treatment simulations.
• Partners HealthCare SystemcoreStrategic or Co-development PartnerHost institution for the i2b2 National Center for Biomedical Computing, based at Harvard-affiliated hospitals in Boston. Dr. Isaac Kohane serves as Director of the i2b2 Center.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerHome to the Department of Biomedical Informatics (DBMI) led by Dr. Isaac Kohane. Multiple board members from Harvard DBMI including Susanne Churchill (Executive Director) and Griffin Weber (original author of i2b2 WebClient).
• Johnson & JohnsonminorStrategic or Co-development PartnerCo-developer of the initial tranSMART data management system in 2009, used initially by researchers in Johnson & Johnson's Centocor R&D division.
• University of MichiganminorStrategic or Co-development PartnerFounding partner of the tranSMART Foundation in 2013, collaborating on the next generation of tranSMART platform development.
• Imperial College LondonminorStrategic or Co-development PartnerFounding partner of the tranSMART Foundation in 2013, contributing to the public-private partnership for translational research informatics.
• Pistoia AllianceminorStrategic or Co-development PartnerFounding partner of the tranSMART Foundation in 2013, supporting pre-competitive collaboration in life sciences research.
• eTRIKSminorStrategic or Co-development PartnerEuropean translational research initiative developing knowledge management systems based on the tranSMART platform.
• TraIT (Translational Research IT)minorStrategic or Co-development PartnerEuropean public-private partnership under CTMM developing translational research informatics based on tranSMART platform.
• The Chartis GroupminorStrategic or Co-development PartnerContributing sponsor providing healthcare strategy and informatics consulting expertise.
• Mass General BrighamminorStrategic or Co-development PartnerSustaining sponsor and home to Dr. Shawn Murphy, Chief Research Information Officer. Developed Research Patient Data Registry with 7 million patients.
• 4CE ConsortiumcoreStrategic or Co-development PartnerConsortium for Clinical Characterization of COVID-19 by EHR, initiated by Dr. Kohane in response to the COVID-19 pandemic, enabling international collaboration on COVID-19 research using EHR data.

Scale indicators10 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Flatiron Health: Commercial oncology-focused real-world evidence and clinical research platform. Comparable in clinical and translational research data infrastructure, but as a specialized commercial platform with pharma and provider customers.
• TriNetX: Commercial global health research network enabling cohort discovery and real-world evidence across hundreds of healthcare organizations. Comparable in translational research and clinical trial feasibility use cases, but as a commercial alternative with proprietary technology.
• Veeva Systems: Commercial cloud software for life sciences, including clinical research and translational informatics offerings. Comparable in pharma-facing clinical and translational research software, but as a public commercial vendor with broad portfolio.
• Palantir Foundry: Enterprise data integration and analytics platform with deep life sciences and healthcare adoption across major pharma and biomedical institutions. Comparable in large-scale biomedical data integration and analytics, but as a broad commercial incumbent.

Direct peers

• OpenClinica: Open-source clinical trial data capture and management software. Directly comparable in open-source clinical trial informatics positioning and similar regulatory and academic customer segments.
• OHDSI (Observational Health Data Sciences and Informatics): Open-source international collaborative with a similar member-driven model and OMOP common data model, focused on generating clinical evidence from observational health data. Directly comparable as a community-led, non-profit open-source clinical research informatics initiative.
• REDCap Consortium: Open-source electronic data capture platform widely used by academic medical centers for clinical and translational research. Highly comparable in open-source license, academic medical center customer base, and free distribution model.

Emerging players

• DNAnexus: Cloud-based platform for biomedical data analysis and genomics, including clinical genomics and translational research workflows. Comparable for genomic and clinical data integration emphasis, but with a commercial SaaS model.
• Seven Bridges: Bioinformatics and genomics data analysis platform supporting translational and clinical research. Comparable in biomedical data integration and analysis, but operating as a commercial platform with enterprise customers.

Others

• Pistoia Alliance: Global not-for-profit alliance promoting pre-competitive collaboration in life sciences R&D. Comparable as a fellow foundation-style entity that promotes pre-competitive data sharing, and is itself a founding partner of tranSMART.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/i2b2transmart
• YouTubeyoutube.com/channel/UC3hy0Az4VYs6TZgN79-w8TA
• Facebookfacebook.com/i2b2tranSMART
• LinkedInlinkedin.com/company/3032761

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about i2b2 tranSMART Foundation